ACT-HIB 10mcg / 0.5ml powder+solvent for injection suspension in pre-filled syringe medication leaflet

J07AG01 • Haemophilus influenzae type B vaccine • Antiinfectives for systemic use | Bacterial vaccines | Haemophilus influenzae B vaccines

The Haemophilus influenzae type B (Hib) vaccine is used to prevent infections caused by this bacterium, which can include meningitis, pneumonia, epiglottitis, and septicemia. The vaccine contains purified capsular polysaccharides from Haemophilus influenzae type B, conjugated to a carrier protein to stimulate a stronger immune response, especially in infants and young children.

The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. It is included in national immunization programs in many countries due to its effectiveness in reducing the incidence of severe diseases caused by Hib.

Common side effects include pain at the injection site, mild fever, and irritability. In rare cases, severe allergic reactions may occur.

The Haemophilus influenzae type B vaccine is an essential measure for protecting children's health and reducing mortality associated with severe infections caused by this bacterium.